X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1563) 1563
animals (1145) 1145
index medicus (1076) 1076
receptor, par-1 - metabolism (901) 901
thrombin (798) 798
male (517) 517
mice (480) 480
thrombin - pharmacology (401) 401
receptor, par-1 (392) 392
cells, cultured (391) 391
expression (383) 383
female (379) 379
receptor, par-1 - genetics (370) 370
signal transduction (359) 359
biochemistry & molecular biology (356) 356
par-1 (354) 354
hematology (352) 352
receptor, par-1 - antagonists & inhibitors (339) 339
thrombin - metabolism (330) 330
rats (328) 328
cell biology (319) 319
receptors, thrombin - metabolism (310) 310
thrombin receptor (282) 282
peripheral vascular disease (265) 265
phosphorylation (253) 253
inflammation (239) 239
receptor, par-1 - physiology (216) 216
pharmacology & pharmacy (208) 208
protease-activated receptors (187) 187
calcium - metabolism (185) 185
endothelial-cells (185) 185
molecular-cloning (184) 184
article (182) 182
neurosciences (179) 179
protease-activated receptor-1 (179) 179
cell line (178) 178
middle aged (175) 175
cells (173) 173
receptor, par-1 - agonists (169) 169
mice, inbred c57bl (164) 164
receptors, thrombin - physiology (159) 159
proteases (157) 157
oligopeptides - pharmacology (156) 156
immunohistochemistry (154) 154
receptors, thrombin - genetics (154) 154
cell line, tumor (153) 153
receptor, par-2 - metabolism (152) 152
blood platelets - metabolism (151) 151
signal transduction - drug effects (151) 151
dose-response relationship, drug (148) 148
mice, knockout (143) 143
oncology (143) 143
research (142) 142
up-regulation (141) 141
proteins (139) 139
rna, messenger - metabolism (138) 138
analysis (137) 137
signal transduction - physiology (136) 136
adult (132) 132
blood platelets - drug effects (132) 132
aged (128) 128
peptide fragments - pharmacology (128) 128
activation (124) 124
peptides (124) 124
coagulation (123) 123
amino acid sequence (121) 121
cancer (121) 121
apoptosis (119) 119
in-vitro (117) 117
physiological aspects (117) 117
reverse transcriptase polymerase chain reaction (117) 117
tissue factor (116) 116
cardiovascular system (115) 115
disease models, animal (114) 114
par1 (114) 114
time factors (114) 114
protease-activated receptor (113) 113
gene expression (112) 112
inhibition (111) 111
molecular sequence data (111) 111
receptor, par-2 (111) 111
thrombin - physiology (110) 110
cardiac & cardiovascular systems (108) 108
angiogenesis (105) 105
abridged index medicus (104) 104
endothelial cells - metabolism (104) 104
platelet activation (103) 103
protein-serine-threonine kinases - metabolism (103) 103
endothelium (102) 102
mechanism (102) 102
platelet aggregation - drug effects (101) 101
platelets (101) 101
receptors, thrombin - agonists (100) 100
pathology (99) 99
metastasis (96) 96
in vitro techniques (95) 95
receptors (94) 94
immunology (93) 93
physiology (91) 91
rats, sprague-dawley (91) 91
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2246) 2246
Chinese (18) 18
Japanese (12) 12
French (11) 11
Russian (8) 8
German (3) 3
Czech (1) 1
Italian (1) 1
Korean (1) 1
Portuguese (1) 1
Romanian (1) 1
Spanish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Nature, ISSN 0028-0836, 04/2008, Volume 452, Issue 7187, pp. 654 - 658
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 08/2012, Volume 10, Issue 8, pp. 1675 - 1684
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2012, Volume 366, Issue 15, pp. 1404 - 1413
Patients with atherosclerotic vascular disease were randomly assigned to receive the thrombin antagonist vorapaxar or placebo. Vorapaxar reduced the rate of... 
ATOPAXAR | MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | EFFICACY | SAFETY | TOLERABILITY | DOUBLE-BLIND | PRASUGREL | LESSONS | ANTAGONISTS | ASPIRIN | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Pyridines - adverse effects | Cardiovascular Diseases - mortality | Female | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Double-Blind Method | Hemorrhage - epidemiology | Receptor, PAR-1 - antagonists & inhibitors | Kaplan-Meier Estimate | Peripheral Arterial Disease - drug therapy | Stroke - drug therapy | Lactones - adverse effects | Lactones - therapeutic use | Retreatment | Myocardial Infarction - drug therapy | Brain Ischemia - drug therapy | Intracranial Hemorrhages - chemically induced | Intracranial Hemorrhages - epidemiology | Aged | Hemorrhage - chemically induced | Prevention | Drugs | Aggregation | Dose-response relationship (Biochemistry) | Atheroembolism | Blood platelets | Atherosclerosis | Product/Service Evaluations | Dosage and administration | Drug therapy | Myocardial infarction | Cerebral infarction | Stroke | Aspirin | Heart attacks | Proteinase-activated receptor 1 | Thrombin | Hemorrhage | Patients | Bleeding | Disease prevention | Ischemia | Arteriosclerosis | Death | Cardiovascular diseases | Health risk assessment | Computer Science | Medical Imaging
Journal Article